We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metabolic management of microenvironment acidity in glioblastoma.
- Authors
Seyfried, Thomas N.; Arismendi-Morillo, Gabriel; Zuccoli, Giulio; Lee, Derek C.; Duraj, Tomas; Elsakka, Ahmed M.; Maroon, Joseph C.; Mukherjee, Purna; Linh Ta; Shelton, Laura; D'Agostino, Dominic; Kiebish, Michael; Chinopoulos, Christos
- Abstract
Glioblastoma (GBM), similar to most cancers, is dependent on fermentation metabolism for the synthesis of biomass and energy (ATP) regardless of the cellular or genetic heterogeneity seen within the tumor. The transition from respiration to fermentation arises from the documented defects in the number, the structure, and the function of mitochondria and mitochondrial-associated membranes in GBM tissue. Glucose and glutamine are the major fermentable fuels that drive GBM growth. The major waste products of GBM cell fermentation (lactic acid, glutamic acid, and succinic acid) will acidify the microenvironment and are largely responsible for drug resistance, enhanced invasion, immunosuppression, and metastasis. Besides surgical debulking, therapies used for GBM management (radiation, chemotherapy, and steroids) enhance microenvironment acidification and, although often providing a timelimited disease control, will thus favor tumor recurrence and complications. The simultaneous restriction of glucose and glutamine, while elevating nonfermentable, anti-inflammatory ketone bodies, can help restore the pH balance of the microenvironment while, at the same time, providing a non-toxic therapeutic strategy for killing most of the neoplastic cells.
- Subjects
GLIOBLASTOMA multiforme; GLUTAMIC acid; BIOMASS energy; SUCCINIC acid; WASTE products
- Publication
Frontiers in Oncology, 2022, Vol 12, p1
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2022.968351